Related Experiment Video
Updated: Jun 5, 2025
02:49
Author Spotlight: A Multi-Depth Porcine Model for Comprehensive Study of Burn Injuries and Healing Processes
Published on: February 23, 2024
1.0K
Vasoactive Agents in Burn Patients: Perspectives on Angiotensin-II
Scott W Mueller1, Nicolas M Tran2, Kevin D Betthauser3
1Department of Pharmacy, University of Colorado Health, Aurora, CO, United States.
Summary
This review examines vasoactive agents for severe burn shock and septic shock, highlighting synthetic angiotensin-II (AT-II) as a potential new therapy. Research is needed to confirm its effectiveness in burn patients.
Area of Science:
- Critical Care Medicine
- Trauma Surgery
- Pharmacology
Background:
- Severe burn injuries often lead to shock, requiring vasoactive agents for hemodynamic support.
- Existing therapies like catecholamines and vasopressin have limitations, prompting exploration of novel agents.
- The renin-angiotensin-aldosterone system (RAAS) is frequently dysregulated in burn and septic shock.
Purpose of the Study:
- To review current vasoactive agents used in acute burn shock resuscitation.
- To explore the potential role of synthetic angiotensin-II (AT-II) in managing burn and septic shock.
- To discuss the physiological rationale and existing data for synthetic AT-II in shock.
Main Methods:
- Narrative review of existing literature on vasoactive agents in burn and septic shock.
- Analysis of the pathophysiology of burn injury and its impact on the RAAS.
- Evaluation of available data on synthetic AT-II in distributive shock populations.
Main Results:
- Catecholamines and vasopressin are standard but have drawbacks.
- Synthetic AT-II shows promise in improving hemodynamics in other distributive shock cases.
- Limited data currently exists on synthetic AT-II specifically for acute burn shock and septic shock in burn patients.
Conclusions:
- Synthetic AT-II presents a potential therapeutic option for severe burn and septic shock.
- Further research is crucial to establish the safety and efficacy of synthetic AT-II in burn populations.
- Understanding RAAS dysregulation in burn shock is key to optimizing treatment strategies.
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
581
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
581
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
385
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
385
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
477
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
477
01:25Antihypertensive Drugs: Direct Renin Inhibitors
490
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
490
01:22Heart Failure Drugs: β-Blockers
316
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
316
01:22Burn Injuries
2.4K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
2.4K